Dimensional Fund Advisors LP Collegium Pharmaceutical, Inc Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 861,191 shares of COLL stock, worth $29.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

861,191

Previous 909,006 5.26%

Holding current value

$29.5 Million

Previous $27.1 Million 6.15%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$24.67 - $30.44 $1.18 Million - $1.46 Million	-47,815 Reduced 5.26%	861,191 $25.5 Million
Q1 2025 May 13, 2025	SELL	$28.04 - $33.91 $1.87 Million - $2.27 Million	-66,808 Reduced 6.85%	909,006 $27.1 Million
Q4 2024 Feb 13, 2025	SELL	$28.61 - $41.86 $2.08 Million - $3.05 Million	-72,840 Reduced 6.95%	975,814 $28 Million
Q3 2024 Nov 07, 2024	BUY	$31.4 - $39.07 $302,382 - $376,244	9,630 Added 0.93%	1,048,654 $40.5 Million
Q2 2024 Aug 09, 2024	BUY	$31.36 - $39.99 $623,311 - $794,841	19,876 Added 1.95%	1,039,024 $33.5 Million
Q1 2024 May 10, 2024	SELL	$31.23 - $40.91 $626,786 - $821,063	-20,070 Reduced 1.93%	1,019,148 $39.6 Million
Q4 2023 Feb 07, 2024	BUY	$21.16 - $30.8 $624,833 - $909,493	29,529 Added 2.92%	1,039,218 $32 Million
Q3 2023 Nov 09, 2023	BUY	$21.23 - $24.28 $584,610 - $668,598	27,537 Added 2.8%	1,009,689 $22.6 Million
Q2 2023 Aug 09, 2023	BUY	$21.06 - $24.0 $530,775 - $604,872	25,203 Added 2.63%	982,152 $21.1 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $863,558 - $1.12 Million	37,546 Added 4.08%	956,949 $23 Million
Q4 2022 Feb 09, 2023	BUY	$16.14 - $23.55 $1.12 Million - $1.63 Million	69,089 Added 8.13%	919,403 $21.3 Million
Q3 2022 Nov 10, 2022	BUY	$15.46 - $20.1 $476,276 - $619,220	30,807 Added 3.76%	850,314 $13.6 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $419,632 - $616,168	-29,510 Reduced 3.48%	819,507 $14.5 Million
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $866,037 - $1.13 Million	50,351 Added 6.3%	849,017 $17.3 Million
Q4 2021 Feb 09, 2022	BUY	$17.5 - $21.35 $740,775 - $903,745	42,330 Added 5.6%	798,666 $14.9 Million
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $347,403 - $496,933	-19,572 Reduced 2.52%	756,336 $14.9 Million
Q2 2021 Aug 12, 2021	BUY	$21.74 - $25.28 $4.21 Million - $4.89 Million	193,468 Added 33.22%	775,908 $18.3 Million
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $425,309 - $576,653	-22,094 Reduced 3.65%	582,440 $13.8 Million
Q4 2020 Feb 25, 2021	BUY	$17.83 - $22.29 $10.8 Million - $13.5 Million	604,534 New	604,534 $12.1 Million

Others Institutions Holding COLL

# of Institutions

241

Shares Held

36.4M

Call Options Held

52.5K

Put Options Held

200

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.17B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Collegium Pharmaceutical, Inc Transaction History